TuHURA Biosciences Inc. (HURA)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
4.62
0.03 (0.65%)
At close: Jan 15, 2025, 2:31 PM
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY11 | FY10 | FY09 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | 32.00K | 10.00K | 16.35K | 24.53K | 16.68K | 10.29K | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | -32.00K | -10.00K | -16.35K | -24.53K | -16.68K | -10.29K | n/a | n/a | n/a | n/a | n/a |
Operating Income | -29.76M | -9.93M | -7.25M | -21.57M | -8.14M | -8.40M | -11.17M | -8.32M | -6.21M | -4.72M | -6.29M | -18.89K | -33.14K | -5.58K |
Interest Income | 89.67K | 57.35K | n/a | n/a | 75.00K | 60.70K | 33.24K | 457.00 | 108.00 | 363.00 | 2.49K | n/a | n/a | n/a |
Pretax Income | -29.32M | -9.37M | -7.02M | -38.30M | -9.13M | -8.05M | -11.14M | -8.08M | -8.86M | -4.35M | -8.29M | -18.89K | -33.14K | -5.58K |
Net Income | -29.32M | -9.37M | -7.02M | -38.30M | -9.13M | -8.05M | -11.14M | -8.08M | -8.86M | -4.35M | -8.29M | -18.89K | -33.14K | -5.58K |
Selling & General & Admin | 4.14M | 2.01M | 2.38M | 9.72M | 4.50M | 4.72M | 4.02M | 3.30M | 2.84M | 2.17M | 3.95M | 18.89K | 33.14K | 5.58K |
Research & Development | 9.40M | 7.93M | 4.88M | 11.81M | 3.63M | 3.66M | 7.13M | 5.00M | 3.36M | 2.56M | 2.34M | n/a | n/a | n/a |
Other Expenses | 16.22M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 29.76M | 9.93M | 7.25M | 21.54M | 8.13M | 8.38M | 11.15M | 8.30M | 6.20M | 4.72M | 6.29M | 18.89K | 33.14K | 5.58K |
Interest Expense | 18.69K | n/a | 629.29K | 120.00K | n/a | n/a | n/a | n/a | n/a | 2.09K | 8.02K | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 29.76M | 9.93M | 7.25M | -21.57M | -8.14M | -8.40M | -11.17M | -8.32M | -6.21M | -4.72M | -6.29M | -18.89K | -33.14K | -5.58K |
Income Tax | -1 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 68.01M | 46.28K | 42.03M | 14.79K | 5.97K | 1.47K | 1.19K | 688.40 | 625.63 | 543.82 | 423.82 | 151.85 | 288.14 | 120.56 |
Shares Outstanding (Diluted) | 68.01M | 46.28K | 42.03M | 14.79K | 5.97K | 1.47K | 1.19K | 688.40 | 625.63 | 543.82 | 423.82 | 151.85 | 288.14 | 120.56 |
EPS (Basic) | -0.12 | -202.39 | -0.17 | -2.81K | -1.53K | -5.52K | -9.49K | -12.89K | -14.55K | -7.99K | -19.56K | -124.36 | -115 | -46.3 |
EPS (Diluted) | -0.12 | -202.39 | -0.17 | -2.81K | -1.53K | -5.52K | -9.49K | -12.89K | -14.55K | -7.99K | -19.56K | -124.36 | -115 | -46.3 |
EBITDA | -29.12M | -9.56M | -6.01M | -38.15M | -9.12M | -8.03M | -11.11M | -8.07M | -8.85M | -4.35M | -8.28M | -18.89K | -33.14K | -5.58K |
Depreciation & Amortization | 177.38K | 373.09K | 380.69K | 32.00K | 10.00K | 16.35K | 24.53K | 16.68K | 10.29K | 378.97K | -1.99M | n/a | n/a | n/a |